Overview
Robert Sutphin is a Hematologist and an Oncologist practicing medicine in Orlando, Florida.
Dr. Sutphin is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Embryonal Tumor with Multilayered Rosettes, Medulloblastoma, Neuroblastoma, and Glioma.
He is actively involved in clinical research, co-authoring 8 peer reviewed articles.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
Locations
92 W Miller St Fl 2, Orlando, FL 32806
Additional Areas of Focus
Dr. Sutphin has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Orlando Health Cancer Institute - Downtown Orlando
Jennifer Tseng, MD, hematologist/medical oncologist, is the Thoracic/Head and Neck Specialty Section leader for Medical Oncology and the associate director of Clinical Research for Medical Oncology at Orlando Health Cancer Institute.Dr. Tseng received her medical degree from Duke University School of Medicine. She completed her residency and served as assistant chief resident in internal medicine at Duke University Medical Center. She completed a fellowship in medical oncology and hematology at The University of Texas MD Anderson Cancer Center in Houston. She is board-certified in internal medicine and medical oncology and board-eligible in hematology. Dr. Tseng has received several honors and awards, including the C.D. Howe Award for clinical excellence in medical oncology and a Clinical Research Award from MD Anderson, the American Medical Women's Award, Hewlett Packard Award, the Alpha Omega Alpha Research Symposium Award from Duke University and a Beneficial-Hodgson scholarship from The Johns Hopkins University. She was also awarded Attending of the Year from the Internal Medicine Residency Program from Orlando Regional Medical Center and received the Exemplary Physician Colleague Award from Orlando Health in 2009.In addition to her clinical studies, Dr. Tseng has published research on various topics including molecular alterations in lung cancer and novel agents in the treatment of head and neck cancer. She has recently presented at the Annual Thoracic Oncology Symposium of the Puerto Rican Society of Hematology Oncology and spoke on neoadjuvant and adjuvant treatment strategies in lung cancer. Dr. Tseng is highly rated in 29 conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, Lung Adenocarcinoma, and Bone Marrow Aspiration. Dr. Tseng is board certified in American Board Of Internal Med. - Medical Oncology and American Board Of Internal Medicine.
Orlando Health Cancer Institute - Downtown Orlando
Dr. Tirrell Johnson is a board-certified medical oncologist at the Orlando Health Cancer Institute. His specialties include: Head and neck cancers Thoracic cancers Melanoma Sarcoma He is a member of the team pioneering a breakthrough protocol using tumor-infiltrating lymphocytes to address aggressive, late-stage melanoma. Dr. Johnson's Training Dr. Johnson earned a bachelor's degree in chemical engineering from Florida A&M University in Tallahassee, graduating magna cum laude, and received his medical degree from the University of Florida in Gainesville. He completed an internal medicine residency at Orlando Health Orlando Regional Medical Center and a fellowship in hematology and oncology at Brown University Medical School's teaching hospitals in Providence, Rhode Island. About Dr. Johnson Dr. Johnson is board certified in internal medicine and medical oncology by the American Board of Internal Medicine. His professional memberships include the American College of Physicians, American Society of Clinical Oncology and American Society of Hematology. Dr. Johnson received an Orlando Health award for outstanding multidisciplinary involvement with staff. He has served as the primary investigator for clinical trials studying several forms of chemotherapy for advanced head and neck cancers and thoracic malignancies. Dr. Johnson is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and EGFR Positive Lung Cancer. Dr. Johnson is board certified in American Board Of Internal Med. - Medical Oncology and American Board Of Internal Medicine.
Orlando Health Cancer Institute - Downtown Orlando
Omar Kayaleh, MD, serves as the medical oncology team leader for the Gastrointestinal Cancers Specialty Section and as a member of the Breast Cancer, Genitourinary Cancers, Hematology, Lymphoma/Myeloma and Thoracic/Head and Neck Cancers Specialty Sections at Orlando Health Cancer Institute. He also served as chairman of the Department of Internal Medicine as well as chief of the Hematology/ Oncology Specialty Section at Orlando Health Cancer Institute.Dr. Kayaleh received his medical degree from the University of Florida, completed a residency in internal medicine at Franklin Square Hospital in Baltimore and fulfilled a fellowship at the Medical University of South Carolina.Dr. Kayaleh is board-certified in internal medicine and in the specialties of medical oncology and hematology. He has held many offices and memberships on numerous medical staff committees, including Pharmacy and Therapeutics.He is a member of the Orange County Medical Society, Florida Medical Association, American Medical Association, American Society of Hematology, and the American Society of Clinical Oncology. Dr. Kayaleh is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Colorectal Cancer, Colorectal Cancer, and Lynch Syndrome. Dr. Kayaleh is board certified in American Board Of Internal Med. - Medical Oncology and American Board Of Internal Medicine - Hematology.
Frequently Asked Questions about Dr. Robert Sutphin
How do I make an appointment with Dr. Robert Sutphin?
You can book an appointment with Dr. Robert Sutphin by calling their office at 321-841-8588. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Robert Sutphin a top-rated expert for Embryonal Tumor with Multilayered Rosettes?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Robert Sutphin is classified as an Advanced expert for Embryonal Tumor with Multilayered Rosettes, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Robert Sutphin specialize in?
While Dr. Robert Sutphin is a Hematology, they have specific expertise in Embryonal Tumor with Multilayered Rosettes, Medulloblastoma, and Neuroblastoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Robert Sutphin participate in research or clinical trials?
Yes. Dr. Robert Sutphin has published 8 articles and abstracts on conditions like Embryonal Tumor with Multilayered Rosettes. You can view a list of Dr. Robert Sutphin's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Robert Sutphin accept my insurance?
Dr. Robert Sutphin accepts most major insurance plans, including Sunshine Health. We recommend calling the office directly at 321-841-8588 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Embryonal Tumor with Multilayered Rosettes
- MedulloblastomaDr. Sutphin isAdvanced. Learn about Medulloblastoma.
- Experienced
- GliomaDr. Sutphin isExperienced. Learn about Glioma.
- NeuroblastomaDr. Sutphin isExperienced. Learn about Neuroblastoma.


